Iv To Po Switch - Infectious Diseases

Relevant Publications

Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections.

Issue Release: 2024

Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia.

Issue Release: 2024

Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials.

Issue Release: 2024

Continued Intravenous Versus First Week Transition to Oral Antibiotic Therapy in Bloodstream Infections: A Systematic Review and Meta-Analysis.

Issue Release: 2024

Variation in North American Infectious Disease Specialists\' Practice Regarding Oral and Suppressive Antibiotics for Adult Osteoarticular Infections: Results of an Emerging Infections Network (EIN) Survey.

Issue Release: 2024

Antibiotic prescribing for adults with group A streptococcal bacteremia in a large healthcare system.

Issue Release: 2023

Impact of clinical pharmacist-led interventions on switching from intravenous-to-oral antibiotics in patients with infectious diseases at a Vietnamese hospital.

Issue Release: 2023

Assessment of Intravenous Antibiotics to Peroral Antibiotics Conversion Practice and Its Associated Factor at University of Gondar Comprehensive Specialized Hospital: Prospective Observational Study.

Issue Release: 2022

Effectiveness of antimicrobial stewardship interventions on early switch from intravenous-to-oral antimicrobials in hospitalized adults: A systematic review.

Issue Release: 2022

Implementation of pharmacist-managed early switch from intravenous to oral therapy using electronic identification at a tertiary academic hospital.

Issue Release: 2021

Is Early Oral Antimicrobial Switch Useful for Less Critically Ill Adults with Community-Onset Bacteraemia in Emergency Departments?

Issue Release: 2020

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.

Issue Release: 2020

Early switch/early discharge opportunities for hospitalized patients with methicillin resistant Staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab Emirates.

Issue Release: 2020

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia.

Issue Release: 2019

Comparative Impact of C-Reactive Protein Testing in Hospitalized Patients with Acute Respiratory Tract Infection: A Retrospective Cohort Study.

Issue Release: 2019

Antimicrobial Stewardship Program Perspective: IV-to-PO Switch Therapy.

Issue Release: 2018

Intravenous to oral switch therapy in cancer patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus: A single-center retrospective observational study.

Issue Release: 2018

Single-dose Intravenous Safety, Tolerability, and Pharmacokinetics and Absolute Bioavailability of LCB01-0371.

Issue Release: 2018

Impact of printed antimicrobial stewardship recommendations on early intravenous to oral antibiotics switch practice in district hospitals.

Issue Release: 2018

Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch.

Issue Release: 2017

How are Adenovirus Infections Diagnosed?

What is the Future Outlook for the RBM Partnership?

What are the Common Diseases Caused by Contaminated Food and Water?

What Are Common Infectious Diseases Screened During Check-Ups?

What is Genomic Structure?

What Are Emerging Infectious Diseases?

What are Aedes Mosquitoes?

What is Ebola?

How Is Muscle and Joint Pain Diagnosed in the Context of Infectious Diseases?

What are drug interactions?

Iv To Po Switch - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics